The discovery of a potent series of carboxamide TRPA1 antagonists

被引：7

作者：

Pryde, D. C. ^{[1
,6
]}

Marron, B. ^{[2
]}

West, C. G. ^{[2
]}

Reister, S. ^{[2
]}

Amato, G. ^{[2
]}

Yoger, K. ^{[2
]}

Padilla, K. ^{[2
]}

Turner, J. ^{[3
]}

Swain, N. A. ^{[1
]}

Cox, P. J. ^{[3
]}

Skerratt, S. E. ^{[1
]}

Ryckmans, T. ^{[4
]}

Blakemore, D. C. ^{[1
]}

Warmus, J. ^{[5
]}

Gerlach, A. C. ^{[2
]}

机构：

[1] Pfizer Worldwide Med Chem, Neurosci & Pain Res Unit, Portway Bldg,Granta Pk, Great Abington CB21 6GS, Cambs, England

[2] Icagen Inc, 4222 Emperor Blvd,Suite 350, Durham, NC 27703 USA

[3] Neurosci & Pain Res Unit, Portway Bldg,Granta Pk, Great Abington CB21 6GS, Cambs, England

[4] Pfizer Worldwide Med Chem, Ramsgate Rd, Sandwich CT13 9NJ, Kent, England

[5] Pfizer Worldwide Med Chem, Neurosci & Pain Res Unit, Groton, CT USA

[6] Curadev UK, Innovat House,Discovery Pk, Sandwich CT14 9FF, Kent, England

来源：

MEDCHEMCOMM | 2016年 / 7卷 / 11期

关键词：

BIOLOGICAL EVALUATION; CHANNEL TRPA1; DRUG TARGETS; RECEPTOR; PAIN; INFLAMMATION; ACTIVATE; NEURONS; TRPV1; COLD;

D O I：

10.1039/c6md00387g

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

A series of potent and selective carboxamide TRPA1 antagonists were identified by a high throughput screen. Structure-activity relationship studies around this series are described, resulting in a highly potent example of the series. Pharmacokinetic and skin flux data are presented for this compound. Efficacy was observed in a topical cinnamaldehyde flare study, providing a topical proof of pharmacology for this mechanism. These data suggest TRPA1 antagonism could be a viable mechanism to treat topical conditions such as atopic dermatitis.

引用

页码：2145 / 2158

页数：14

共 50 条

[41] TRPA1 is activated by cooling
Sawada, Yosuke
Hosokawa, Hiroshi
Matsumura, Kiyoshi
Kobayashi, Shigeo
NEUROSCIENCE RESEARCH, 2006, 55 : S140 - S140
[42] No functional TRPA1 in cardiomyocytes
Hoebart, Clara
Rojas-Galvan, Natalia S.
Ciotu, Cosmin I.
Aykac, Ibrahim
Reissig, Lukas F.
Weninger, Wolfgang J.
Kiss, Attila
Podesser, Bruno K.
Fischer, Michael J. M.
Heber, Stefan
ACTA PHYSIOLOGICA, 2021, 232 (04)
[43] TRPA1: the species difference
Chen, Jun
Kym, Philip R.
JOURNAL OF GENERAL PHYSIOLOGY, 2009, 133 (06): : 623 - 625
[44] TRPA1 receptors in cough
Grace, Megan S.
Belvisi, Maria G.
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2011, 24 (03) : 286 - 288
[45] New tricks for TRPA1
Fischer, M. J. M.
ACTA PHYSIOLOGICA, 2015, 213 : 25 - 25
[46] TRPA1: A Gatekeeper for Inflammation
Bautista, Diana M.
Pellegrino, Maurizio
Tsunozaki, Makoto
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75, 2013, 75 : 181 - 200
[47] TRPA1: a molecular view
Meents, Jannis E.
Ciotu, Cosmin I.
Fischer, Michael J. M.
JOURNAL OF NEUROPHYSIOLOGY, 2019, 121 (02) : 427 - 443
[48] TRPA1 CHANNELS IN OSTEOARTHRITIS
Moilanen, E.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 6 - 7
[49] Discovery of non-electrophilic capsaicinoid-type TRPA1 ligands
Del Prete, Danilo
Caprioglio, Diego
Appendino, Giovanni
Minassi, Alberto
Schiano-Moriello, Aniello
Di Marzo, Vincenzo
De Petrocellis, Luciano
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (05) : 1009 - 1011
[50] Discovery of a series of potent arylthiadiazole H3 antagonists
Xiao, Dong
Palani, Anandan
Sofolarides, Michael
Huang, Ying
Aslanian, Robert
Vaccaro, Henry
Hong, Liwu
McKittrick, Brian
West, Robert E., Jr.
Williams, Shirley M.
Wu, Ren-Long
Hwa, Joyce
Sondey, Christopher
Lachowicz, Jean
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (02) : 861 - 864

← 1 2 3 4 5 →